INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 720 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 720 | -98.2% | 0.00% | – |
Q1 2023 | $33 | -34.0% | 39,877 | +23.9% | 0.00% | – |
Q4 2022 | $50 | -99.9% | 32,186 | -20.1% | 0.00% | -100.0% |
Q3 2022 | $69,000 | -22.5% | 40,273 | -22.0% | 0.00% | 0.0% |
Q2 2022 | $89,000 | +18.7% | 51,629 | +146.6% | 0.00% | – |
Q1 2022 | $75,000 | +2.7% | 20,935 | +43.5% | 0.00% | – |
Q4 2021 | $73,000 | +35.2% | 14,590 | +92.3% | 0.00% | – |
Q3 2021 | $54,000 | +1250.0% | 7,589 | +1755.5% | 0.00% | – |
Q2 2021 | $4,000 | 0.0% | 409 | 0.0% | 0.00% | – |
Q1 2021 | $4,000 | +33.3% | 409 | +28.2% | 0.00% | – |
Q4 2020 | $3,000 | -70.0% | 319 | -64.7% | 0.00% | – |
Q3 2020 | $10,000 | +150.0% | 904 | +60.3% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 564 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | +100.0% | 564 | +13.0% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 499 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 499 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 499 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 499 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -33.3% | 499 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | +50.0% | 499 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 499 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | – | 499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |